WGS financials
GeneDx (WGS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
WGS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $427.54M | $298.17M | -$11.80M | -$21.02M | -0.73 |
| 2024 | $305.45M | $194.40M | -$23.21M | -$52.29M | -1.94 |
| 2023 | $202.57M | $90.01M | -$180.60M | -$175.77M | -7.23 |
| 2022 | $234.69M | -$26.75M | -$667.65M | -$548.98M | -53.63 |
| 2021 | $212.19M | -$16.60M | -$446.15M | -$245.39M | -74.93 |
| 2020 | $179.32M | $4.03M | -$241.99M | -$241.34M | -146.94 |
- WGS revenue was $427.54M in fiscal 2025, net income -$21.02M.
Updated 2026-11-07 11:54 UTC